FOR IMMEDIATE RELEASE Inflexxion, Inc. appoints Dr. Jody Green to Chief Scientific Officer WALTHAM, MA (November 30, 2017) – Inflexxion, Inc. announced the appointment of Jody Green, PhD as Chief Scientific Officer, effective November 27. Green brings to Inflexxion a strong background and experience in the drug safety and opioid abuse space. She will lead… Read more »
Month: November 2017
For ASI-MV, BHI-MV, and CHAT customers – Join us on Wednesday, December 14 2017 from 1 pm to 2 pm EST for our webinar titled “Monthly Enhanced Training: ASI-MV & BHI-MV – Bridging data into treatment planning.” This training will include: – Gain an understanding of how to use the ASI-MV & BHI-MV data for… Read more »
See our latest infographic below on the power behind the ASI-MV network. To learn more, visit our behavioral health product suite page.
Taryn Dailey-Govoni, Jared Beaumont, Theresa Cassidy Inflexxion, Inc., Waltham, MA, USA Presented at PAINWeek 2017 Read our poster for “Profiling non-medical use of tapentadol products among recreational drug abusers” here Abstract Purpose Prescription opioid misuse and abuse is a public health epidemic in the United States (ONDCP 2015) and a growing source of morbidity, mortality,… Read more »
Last week the President’s Commission on Combatting Drug Addiction and the Opioid Crisis released its final report, which included a list of 56 recommendations for addressing the many challenges this epidemic imposes on America. The goal of these recommendations, as stated by the Commission, is “to combat the opioid crisis and drug addiction in our… Read more »
Click here to read our latest article, The Power of an Electronic Clinical Assessment for Pain and Opioid Misuse Risk: Leveraging SOAPP & COMM in a Digital Era